Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine

Detalles Bibliográficos
Autores principales: Ellefsen-Lavoie, K, Rockstroh, J, Pollard, R, Pantaleo, G, Podzamczer, D, Asmuth, D, van Lunzen, J, Arastéh, K, Schürmann, D, Peters, B, Clotet, B, Hardy, D, Lazzarin, A, Gatell, J, Sommerfelt, MA, Baksaas, I, Wendel-Hansen, V, Sørensen, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441273/
http://dx.doi.org/10.1186/1742-4690-9-S2-O66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441273/
http://dx.doi.org/10.1186/1742-4690-9-S2-O66

Ejemplares similares